The underestimates of NF1 gene mutations in neurofibromatosis 1 (NF1) have been attributed to the large size of the NF1 gene, the considerable frequency of gross deletions and the common occurrence of splicing defects that are only detectable by cDNA analysis. We here report on a patient with severe NF1 showing at RT-PCR analysis the expected fragment from exon 4b to 8 together with a shortened one with the in-frame skipping of exon 7. Sequencing of the corresponding genomic fragment revealed a G→A transition and a C→A transversion at nucleotide positions 57 and 58 of the 174-bp long exon 7, neither of which was present in the proband's parents or 50 healthy controls. No other variation was found in the entire NF1 coding sequence. The use o...
We describe a G-->A transition within intron 5 of the NF2 gene. This mutation creates a consensus sp...
Many disease-causing splicing mutations described in the literature produce changes in splice sites...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...
Nonsense, missense, and even silent mutation-associated exon skipping is recognized in an increasing...
Abstract Background Neurofibromatosis type 1 is one of the most common autosomal dominant disorders,...
Background: Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecti...
We describe 94 pathogenic NF1 gene alterations in a cohort of 97 Austrian neurofibromatosis type I p...
SummaryStop mutations are known to disrupt gene function in different ways. They both give rise to t...
Background Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecti...
Neurofibromatosis type 1 (NF1) afflicts 1 in 3,000 individuals and is characterized with variable cl...
Genomic variations with no apparent effect ("neutral polymorphisms") may have a significant effect o...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disease. In recent studies on ...
Many disease-causing splicing mutations described in the literature produce changes in splice sites ...
[[abstract]]Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome affecting the ...
Abstract Background Mutation analysis of the neurofibromatosis type 1 (NF1) gene has shown that abou...
We describe a G-->A transition within intron 5 of the NF2 gene. This mutation creates a consensus sp...
Many disease-causing splicing mutations described in the literature produce changes in splice sites...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...
Nonsense, missense, and even silent mutation-associated exon skipping is recognized in an increasing...
Abstract Background Neurofibromatosis type 1 is one of the most common autosomal dominant disorders,...
Background: Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecti...
We describe 94 pathogenic NF1 gene alterations in a cohort of 97 Austrian neurofibromatosis type I p...
SummaryStop mutations are known to disrupt gene function in different ways. They both give rise to t...
Background Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecti...
Neurofibromatosis type 1 (NF1) afflicts 1 in 3,000 individuals and is characterized with variable cl...
Genomic variations with no apparent effect ("neutral polymorphisms") may have a significant effect o...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disease. In recent studies on ...
Many disease-causing splicing mutations described in the literature produce changes in splice sites ...
[[abstract]]Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome affecting the ...
Abstract Background Mutation analysis of the neurofibromatosis type 1 (NF1) gene has shown that abou...
We describe a G-->A transition within intron 5 of the NF2 gene. This mutation creates a consensus sp...
Many disease-causing splicing mutations described in the literature produce changes in splice sites...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...